The University of Tokyo, RIKEN, Nichi-Iko Pharmaceutical Co., Ltd. and Daiichi Sankyo Company, Limited have reached a ba...
Ubie, a Tokyo based HealthTech startup who is the developer of AI-based healthcare products, has raised JPY2 billio...
Healios K.K., Japan's leading clinical-stage biotechnology company, has been creating Universal Donor Cells (U...
Japan based Daiichi Sankyo Company, Limited announced that it has entered into a clinical trial collaboration agreement ...
Japan based Eisai Co., Ltd. has announced that its U.S. subsidiary Eisai Inc. has launched its in-house discovered orexi...
US based Rakuten Medical, Inc., a global biotechnology company developing precision, cell-targeting investigational ther...
Japanese firm Astellas Pharma Inc. has announced that the Japan Ministry of Health, Labour and Welfare (MHLW) has approv...
Japan based Toshiba Corporation and a team led by Professor Yozo Nakazawa at the Department of Pediatrics, Shinshu Unive...
Japanese firm Takeda Pharmaceutical Company Limited is a key leader of a coalition who has announced that world-leading ...
Japanese firm Daiichi Sankyo Company, Limited has announced the launch of ENHERTU® (trastuzumab deruxtecan), a HER2 ...
Japan based FUJIFILM Corporation is commencing a research study to develop Artificial Intelligence (AI)-based technology...
Cytiva (formerly part of GE Healthcare Life Sciences), a global provider of technologies and services that advance and a...
Denmark headquartered AGC Biologics, a global Contract Development and Manufacturing Organization (CDMO) for Biopharmace...
Japan based Eisai Co., Ltd. announced that it has launched New Selbelle Premium Tablets and New Selbelle Premium Fine Gr...
Japan based Shionogi & Co., Ltd. has announced that Shionogi has officially made the decision to develop a prophylac...
Transgene, a biotech company in Tokyo that designs and develops virus-based immunotherapies for the treatment of cancer,...
Gilead Sciences, Inc. has announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has grante...
Daiichi Sankyo Company, Limited and AstraZeneca’s ENHERTU® (fam-trastuzumab deruxtecan-nxki) has been granted ...
